Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Rocio Torres-Ibarra"'
Autor:
Karina Enriquez-Navarro, Angelica Maldonado-Rodriguez, Othon Rojas-Montes, Rocio Torres-Ibarra, Leticia Bucio-Ortiz, Miguel A. De la Cruz, Jesus Torres-Flores, Beatriz Xoconostle-Cazares, Rosalia Lira
Publikováno v:
Annals of Hepatology, Vol 19, Iss 5, Pp 507-515 (2020)
Introduction and aim: Occult hepatitis B virus infection (OBI) is characterized by the presence of replication-competent hepatitis B virus (HBV) DNA in the liver and/or serum of patients with undetectable levels of the HBV surface antigen (HBsAg). Du
Externí odkaz:
https://doaj.org/article/1fdc291d705e47b48a28a5fab18a4310
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Ma-Teresa Alvarez-Muñoz, Rosalia Lira, Hilda A. Valdez-Salazar, Othon Rojas-Montes, Onofre Muñoz, Rocio Torres-Ibarra, Martha Eugenia Ruiz-Tachiquín, Angelica Maldonado-Rodriguez, Alejandro Gómez, Guillermo Vázquez-Rosales, Carlos Cano-Dominguez
Publikováno v:
Archives of Virology. 155:1117-1125
In third-world countries, dried blood samples (DBS) are a convenient alternative to plasma for monitoring viral load during HIV-1 therapy. In this study, we evaluated the feasibility of using DBS to perform HIV-1 drug resistance genotyping in a ViroS
Autor:
Rocio Torres-Ibarra, Francisco Sánchez Ávila, David Kershenobich, Misael Uribe, Julieta Góngora, J.L. Poo, Xochitl García Samper, Carlos Cano, Miguel Parada
Publikováno v:
Annals of Hepatology, Vol 7, Iss 4, Pp 369-375 (2008)
Scopus-Elsevier
Scopus-Elsevier
Background/Aims: Thymalfasin has shown efficacy in the treatment of chronic HCV infection. The aim of this study was to evaluate the efficacy and tolerability of triple therapy with thymalfasin, peginterferon α-2a (PEG-IFN α-2a), and ribavirin in H
Autor:
M. T. Alvarez-Munoz, Angelica Maldonado-Rodriguez, Onofre Muñoz, Juan Pablo Rodriguez-Auad, Guillermo Vázquez-Rosales, Rosalia Lira, Othon Rojas-Montes, Rocio Torres-Ibarra
Publikováno v:
BioMed Research International, Vol 2015 (2015)
BioMed Research International
BioMed Research International
Monitoring antiretroviral therapy using measurements of viral load (VL) and the genotyping of resistance mutations is not routinely performed in low- to middle-income countries because of the high costs of the commercial assays that are used. The ana
Autor:
Henrique Sérgio Moraes Coelho, Nahum Méndez-Sánchez, Mario G. Pessoa, Rodrigo Zapata, Angelo Alves de Mattos, Milagros Dávalos, Miguel Garassini, Marcela Galoppo, Edna Strauss, Margarita Dehesa, Rocio Torres-Ibarra, Francisco Hevia, David Kershenobich, Marco Arrese, Paulo Roberto Lerias de Almeida, Jorge Daruich, Alejandro Soza, Gilberto Castañeda, Hugo Cheinquer, Francisco Javier Bosques Padilla, Guillermo Valladares, Eduardo Fassio, Francisco Sanchez-Avila, Augusto Marroni Claudio, Adrián Gadano, Maribel Rodriguez-Torres, Miguel Contreras, Misael Uribe
Publikováno v:
Annals of Hepatology, Vol 9, Iss, Pp S8-S26 (2010)
Autor:
Lizeth, Vera de León, Jesús Alberto, Juárez Navarro, Marcelino, Díaz Gómez, Jorge, Méndez Navarro, Ruby Ann, Chirino Sprung, Margarita, Dehesa Violante, Leticia, Casillas Davila, María Teresa, Rizo Robles, Rocio, Torres Ibarra, Carlos, Cano Domínguez, Jesús, Nava Estrada, Mayra, Ramos Gómez, María Elena, Hernández, Samuel, Wong González, Monica, Félix Tamayo, M Del Carmen, Corona Lechuga, Alma Rosa, Zárate Negrete, Magdalena, Rangel Jiménez, Heriberto, Rodríguez Hernández, Valentin, González Ortiz, Martha Patricia, Tirado Estrella, María Los de Angeles, Villanueva Carreto, Raymundo, Orta Flores, José Luis, Manteca Argumedo, Isidro, Vázquez Avila, Juan, González Macias, Omar, Razcón Hernández, Pastora, Torres López, Carlos, Bazán Pérez
Publikováno v:
Revista de gastroenterologia de Mexico. 70(1)
To determine the epidemiological situation of Chronic Hepatitis C (CHC) in our country.Chronic Hepatitis C affects 170 million people worldwide, and about 0.7% of Mexican population. There is no enough epidemiological information about CHC in our cou
Autor:
Othon Rojas-Montes, Javier Torres, Fernanda Gutierrez-Escolano, Angelica Maldonado-Rodriguez, M. T. Alvarez-Munoz, Onofre Muñoz, Rocio Torres-Ibarra, Alejandro Gómez, Guillermo Vázquez-Rosales, Rosalia Lira
Publikováno v:
World Journal of Gastroenterology. 20:13530
To determine the frequency of occult hepatitis B infection (OHBI) in a group of human immunodeficiency virus (HIV)-1+/ hepatitis B surface antigen negative (HBsAg)- patients from Mexico.We investigated the presence of OHBI in 49 HIV-1+/HBsAg- patient
Autor:
Jorge L. Poo, Francisco Sánchez Ávila, David Kershenobich, Xochitl García Samper, Rocío Torres-Ibarra, Julieta Góngora, Carlos Cano, Miguel Parada, Misael Uribe
Publikováno v:
Annals of Hepatology, Vol 7, Iss 4, Pp 369-375 (2008)
Background/Aims: Thymalfasin has shown efficacy in the treatment of chronic HCV infection. The aim of this study was to evaluate the efficacy and tolerability of triple therapy with thymalfasin, peginterferon α-2a (PEG-IFN α-2a), and ribavirin in H
Externí odkaz:
https://doaj.org/article/1dba5215ef104a80acc1c8812c403359
Autor:
Nahum Méndez-Sánchez, Adrian Gadano, Angelo Alves de Mattos, Alejandro Soza, Augusto Marroni Claudio, Marcela Galoppo, David Kershenobich, Edna Strauss, Eduardo Fassio, Gilberto Castañeda, Guillermo Valladares, Henrique Sergio Moraes Coelho, Jorge Daruich, Miguel Garassini, Milagros Dávalos, Misael Uribe, Maribel Rodriguez-Torres, Rodrigo Zapata, Marco Arrese, Francisco Sánchez-Ávila, Margarita Dehesa, Francisco Bosques Padilla, Paulo Roberto Lerias de Almeida, Mario Pessoa, Rocío Torres-Ibarra, Francisco Hevia, Miguel Contreras, Hugo Cheinquer
Publikováno v:
Annals of Hepatology, Vol 9, Iss , Pp S8-S26 (2010)
Externí odkaz:
https://doaj.org/article/72c838a6a1d148f0bbb50af7e0bf5bd0